TOM FRINZI
CHAIRMAN, CEO, PRESIDENT
STAAR SURGICAL
WHY: Took over as CEO and president in 2022 from Caren Mason, who drove sales up fourfold for its implantable collamer lens (ICL), which are used to treat a wide range of refractive eye errors.
IN THE NEWS: Unveiled new 2K-SF building for company-owned ophthalmology training center, expanding the company’s footprint in Lake Forest.
NOTABLE: Since receiving FDA approval in 2022 for its latest product, the company has trained 700 U.S. surgeons on how to perform the procedure.
QUOTABLE: “I liked what I saw from the board’s perspective. I’m very bullish on what Staar will become.”
